News About: Pharm. Industry
Which are KOSPI KOSDAQ listed pharmaceutical companies increased in exports?
This year, the average amount of collective exports of KOSPI listed pharmaceutical companies in the 3rd quarter was significantly increased. On the other hand, while the average export ratio to sales was increased in ...
Handok Teva announces co-promotion agreement of ‘Azilect’ with Lundbeck Korea
Handok Teva(CEO Sun-dong Park) signed a co-promotion agreement of ‘Azilect,’ a Parkinson’s disease treatment, with Lundbeck Korea at the Lundbeck Korea headquarters in Seoul on the 30th of December.
Under the term of...
Pharmaceutical industry expanded business into medical equipment
The pharmaceutical industry owning medical equipment has attracted interests as putting effort on related founding sales departments and companies or enlarging outputs. The examples are JW Medical, an affiliate of JW ...
GSK’s Cervarix put backfire on MSD’s GardasilSince the government is expected to practically include cervical cancer vaccines in the National Immunization Program(NIP) business next year, GSK and MSD Korea have exchanged w...
|
.jpg)
Foreigner-owning stock appraisements of listed pharmaceuticals reach KRW 4.7 trillion
It was observed foreigner-owning stock appraisements of listed pharmaceutical companies reached KRW 4.7 trillion.
Moreover, there were the total 10 pharmaceutical companies with more than KRW 1 trillion stock apprais...
Listed pharmaceuticals ‘increase’ R&D investments, but ‘decrease’ its ratios to sales
Although the 3rd quarter’s collective R&D expenses of listed pharmaceutical companies increased this year compared with the same quarter of the last year, the average ratio to sales was decreased in the KOSPI and KOSD...
Bayer requests delay to sell ‘Mercilon’ after NovemberThe decision of the subject to purchase Bayer Korea’s ‘Mercilon’ has been delayed.
On the 30th, the Fair Trade Commission(FTC) announced the delay of the final purchase date of...
|
After the ‘Jackpot’ of Hanmi, other companies’ pipelines attract interests
As Hanmi Pharm, which put all its effort in R&D, signed 6 gigantic license agreements with multinational pharmaceutical companies only this year, other domestic pharmaceutical companies’ pipelines have started to attr...
Green Cross becomes the fourth company succeeding in acquisition of tetravalent vaccine approvalOn the 26th, Green Cross(CEO Eun-cheol Huh) announced acquisition of product approval of G C Flu Pre-filled Syringe Inj, a tetravalent influenza(flu) vaccine, from the Ministry ...
|
President Jae-seung Yoon dominates the governing system of Daewoong groupThe complicated composition of Daewoong Pharmaceutical’s market share among siblings has been organized by the independence of its former vice president, Jae-hoon Yoon(53).
As ...
|
